Salacinol
Salacinol, compound found in Salacia reticulata, is an orally active α-glucosidase/lipase inhibitor. Salacinol inhibits enzymatic activity of intestinal maltase (IC50 = 3.2 μg/mL, Ki = 0.31 μg/mL), sucrase (IC50 = 0.84 μg/mL, Ki = 0.32 μg/mL), and isomaltase (IC50 = 0.59 μg/mL, Ki = 0.47 μg/mL), and inhibits increases in serum glucose levels in sucrose-loaded rats. Salacinol also inhibits pancreatic lipase and lipoprotein lipase. Salacinol can be used for the research of diabetes mellitus.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 200399-47-9
- Formel: C9H18O9S2
- Molecular Weight:334.36
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
α‑glucosidase |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Caco-2 | IC50 |
0.5 μM
Compound: 12, Salacinol
|
Inhibition of maltase in human Caco-2 cell membrane
Inhibition of maltase in human Caco-2 cell membrane
|
[PMID: 18258441] |
In Vitro
Salacinol (300 mg/L; 30 min) significantly inhibits porcine pancreatic lipase activity by 12.6%[1].
Salacinol (100 mg/L; 2 h) significantly inhibits rat adipose tissue-derived lipoprotein lipase activity by 13.6%[1].
Salacinol (100 mg/L; 18 h) reduces remaining triglyceride content in rat epididymal fat-derived adipocytes to 75.3% of vehicle control[1].
Salacinol (30 min) competitively inhibits rat small intestinal brush border membrane vesicle maltase, sucrase, and isomaltase with IC50 values of 3.2, 0.84, and 0.59 μg/mL, respectively, and Ki values of 0.31, 0.32, and 0.47 μg/mL, respectively[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sucrose-induced sucrose-induced Wistar (male, weight 130-170 g)[2]
-
Dosage:1.3 mg/kg; 2.5 mg/kg; 5 mg/kg; 10 mg/kg
-
Administration:p.o.
-
Result:Significantly inhibited the increase in serum glucose.
Chemical Information
-
CAS. Nr. 200399-47-9
-
Molecular Weight 334.36
-
Formel C9H18O9S2
-
SMILES
OC[C@@H]([C@@H](C[S@+]1[C@@H]([C@H]([C@@H](C1)O)O)CO)O)OS(=O)([O-])=O
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Salacinol
- 200399-47-9
- Glycosidase
- Lipase
- isomaltase
- rat small intestinal brush border membrane vesicle
- rat adipose tissue-derived lipoprotein lipase
- diabetes mellitus
- sucrase
- porcine pancreatic lipase
- Salacia reticulata
- rat intestinal maltase
- α-glucosidase
- rat epididymal fat-derived adipocytes
- Inhibitor
- inhibitor
- inhibit